Persistent Asset Partners »

Sellas Life Sciences Group I shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Sellas Life Sciences Group I (SLS) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $53k 758 69.57

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Sellas Life Sciences Group I

BlackRock
Vanguard Group
Vanguard Capital Management
Susquehanna International
Citadel Advisors
Geode Capital Management
State Street Corporation
Vanguard Portfolio Management
Marshall Wace
Morgan Stanley
Vanguard Fiduciary Trust
Dagco
Millennium Management
Northern Trust
UBS Group

View all funds holding Sellas Life Sciences Group I